Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix
S. Riethdorf et al., Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix, INT J GYN P, 20(2), 2001, pp. 177-185
SILs (squamous intraepithelial lesions) comprise a wide spectrum of clinica
lly and biologically heterogeneous lesions ranging from benign proliferatio
ns to precancerous lesions. Telomerase activation plays a critical role in
cellular immortalization and might be important for malignant progression.
The viral oncogenes E6 and E7 are the principal transforming genes of high-
risk HPVs and are important in HPV-associated immortalization and neoplasti
c transformation. In this study we investigated the relationship between te
lomerase activity, telomerase RNA, and HPV 16/18 oncogene expression in low
- and high-grade Sns and SCCs (squamous cell carcinomas) of the cervix uter
i. Telomerase activity was examined by the TRAP-assay and expression of the
telomerase RNA (hTR) and HPV 16/18 E6/E7 oncogenes by RNA/RNA-in situ hybr
idization (ISH). The associated HPV-type was determined by PCR. Telomerase
activity was observed in 25/29 (86%) SCCs, 31/41 (76%) high-grade SILs, 6/1
4 (43%) low-grade SILs, and 1/28 (3.6%) normal cervical tissues. Expression
of hTR and viral oncogenes increased significantly with histopathologic se
verity of the lesion (p < 0.0001). A correlation was found between telomera
se activity and intensity of viral oncogene expression. These findings sugg
est that telomerase activation occurs early in cervical carcinogenesis and
is predominantly found in high-grade SILs and cervical SCCs. Our findings s
upport current experimental data that suggest that telomerase is at least p
artially activated by viral oncogenes of high-risk HPV types. Telomerase ac
tivity with concomitant strong viral oncogene expression might therefore ch
aracterize a subset of lesions that are at risk for malignant progression.